Appendix Table 4.
Point Estimates and 95% CIs for the Odds of CRC Deaths Associated With 5 to 10 PCP Visits Versus 0 to 1 PCP Visit*
OR† | P1‡ | P0§ |
|||||
---|---|---|---|---|---|---|---|
0.05 | 0.1 | 0.2 | 0.3 | 0.5 | 0.8 | ||
0.9 | 0.05 | 0.86 (0.82–0.90) | – | – | – | – | – |
0.1 | 0.86 (0.82–0.90) | 0.86 (0.82–0.90) | – | – | – | – | |
0.2 | 0.87 (0.83–0.91) | 0.87 (0.83–0.91) | 0.86 (0.82–0.90) | – | – | – | |
0.3 | 0.88 (0.84–0.92) | 0.88 (0.84–0.92) | 0.87 (0.83–0.91) | 0.86 (0.82–0.90) | – | – | |
0.5 | 0.90 (0.86–0.94) | 0.90 (0.85–0.94) | 0.89 (0.85–0.93) | 0.88 (0.84–0.92) | 0.86 (0.82–0.90) | – | |
0.8 | 0.93 (0.89–0.97) | 0.93 (0.88–0.97) | 0.92 (0.87–0.96) | 0.91 (0.86–0.95) | 0.89 (0.85–0.93) | 0.86 (0.82–0.90) | |
0.75 | 0.05 | 0.86 (0.82–0.90) | – | – | – | – | – |
0.1 | 0.87 (0.83–0.91) | 0.86 (0.82–0.90) | – | – | – | – | |
0.2 | 0.89 (0.85–0.94) | 0.883 (0.842–0.924) | 0.86 (0.82–0.9) | – | – | – | |
0.3 | 0.92 (0.88–0.96) | 0.91 (0.86–0.95) | 0.88 (0.84–0.92) | 0.86 (0.82–0.90) | – | – | |
0.5 | 0.97 (0.93–1.02) | 0.96 (0.91–1.00) | 0.93 (0.89–0.98) | 0.91 (0.87–0.95) | 0.86 (0.82–0.90) | – | |
0.8 | 1.06 (1.01–1.11) | 1.05 (1.05–1.10) | 1.02 (0.97–1.07) | 0.99 (0.95–1.04) | 0.94 (0.90–0.98) | 0.86 (0.82–0.90) |
CRC = colorectal cancer; OR = odds ratio; PCP = primary care physician.
With adjustment for an unmeasured confounder having an OR of CRC death of 0.9 or 0.75 (n = 54 160). Bold indicates that CIs include 1.0 (PCP effect becomes null) or are >1.0 (PCP effect is reversed).
OR of CRC death comparing persons with an unmeasured confounder vs. those without the confounder.
Prevalence of unmeasured confounder in those with 5 to 10 PCP visits.
Prevalence of unmeasured confounder in those with 0 to 1 PCP visit.